ARIA-EAACI statement on asthma and COVID-19 (June 2, 2020)

Jean Bousquet; Marek Jutel; Cezmi A. Akdis; Ludger Klimek; Oliver Pfaar; Kari C. Nadeau; Thomas Eiwegger; Anna Bedbrook; Ignacio J. Ansotegui; Josep M. Anto; Claus Bachert; Eric D. Bateman; Kazi S. Bennoor; Elena Camelia Berghea; Karl Christian Bergmann; Hubert Blain; Mateo Bonini; Sinthia Bosnic-Anticevich; Louis Philippe Boulet; Luisa Brussino; Roland Buhl; Paulo Camargos; Giorgio Walter Canonica; Victoria Cardona; Thomas Casale; Sharon Chinthrajah; Mübeccel Akdis; Tomas Chivato; George Christoff; Alvaro A. Cruz; Wienczyslawa Czarlewski; Stefano Del Giacco; Hui Du; Yehia El-Gamal; Wytske J. Fokkens; Joao A. Fonseca; Yadong Gao; Mina Gaga; Bilun Gemicioglu; Maia Gotua; Tari Haahtela; David Halpin; Eckard Hamelmann; Karin Hoffmann-Sommergruber; Marc Humbert; Nataliya Ilina; Juan Carlos Ivancevich; Guy Joos; Musa Khaitov; Bruce Kirenga; Edward F. Knol; Fanny W. Ko; Seppo Koskinen; Marek L. Kowalski; Helga Kraxner; Dmitry Kudlay; Piotr Kuna; Maciej Kupczyk; Violeta Kvedariene; Amir H. Abdul Latiff; Lan T. Le; Michael Levin; Desiree Larenas-Linnemann; Renaud Louis; Mohammad R. Masjedi; Erik Melén; Florin Mihaltan; Branislava Milenkovic; Yousser Mohammad; Mario Morais-Almeida; Joaquim Mullol; Leyla Namazova; Hugo Neffen; Elisabete Nunes; Paul O’Byrne; Robyn O’Hehir; Liam O’Mahony; Ken Ohta; Yoshitaka Okamoto; Gabrielle L. Onorato; Petr Panzner; Nikos G. Papadopoulos; Gianni Passalacqua; Vincenzo Patella; Ruby Pawankar; Nhân Pham-Thi; Bernard Pigearias; Todor A. Popov; Francesca Puggioni; Frederico S. Regateiro; Giovanni Rolla; Menachem Rottem; Boleslaw Samolinski; Joaquin Sastre; Jurgen Schwarze; Aziz Sheikh; Nicola Scichilone; Manuel Soto-Martinez; Manuel Soto-Martinez; Milan Sova; Stefania Nicola; Rafael Stelmach; Charlotte Suppli-Ulrik; Luis Taborda-Barata; Teresa To; Peter Valentin Tomazic; Sanna Toppila-Salmi; Ioanna Tsiligianni; Omar Usmani; Arunas Valiulis; Maria Teresa Ventura; Giovanni Viegi; Theodor Vontetsianos; De Yun Wang; Sian Williams; Gary W.K. Wong; Arzu Yorgancioglu; Mario Zernotti; Mihaela Zidarn; Torsten Zuberbier; Ioana Agache

doi:10.1111/all.14471

ARIA-EAACI statement on asthma and COVID-19 (June 2, 2020)

Jean Bousquet^*, Marek Jutel, Cezmi A. Akdis, Ludger Klimek, Oliver Pfaar, Kari C. Nadeau, Thomas Eiwegger, Anna Bedbrook, Ignacio J. Ansotegui, Josep M. Anto, Claus Bachert, Eric D. Bateman, Kazi S. Bennoor, Elena Camelia Berghea, Karl Christian Bergmann, Hubert Blain, Mateo Bonini, Sinthia Bosnic-Anticevich, Louis Philippe Boulet, Luisa BrussinoRoland Buhl, Paulo Camargos, Giorgio Walter Canonica, Victoria Cardona, Thomas Casale, Sharon Chinthrajah, Mübeccel Akdis, Tomas Chivato, George Christoff, Alvaro A. Cruz, Wienczyslawa Czarlewski, Stefano Del Giacco, Hui Du, Yehia El-Gamal, Wytske J. Fokkens, Joao A. Fonseca, Yadong Gao, Mina Gaga, Bilun Gemicioglu, Maia Gotua, Tari Haahtela, David Halpin, Eckard Hamelmann, Karin Hoffmann-Sommergruber, Marc Humbert, Nataliya Ilina, Juan Carlos Ivancevich, Guy Joos, Musa Khaitov, Bruce Kirenga, Edward F. Knol, Fanny W. Ko, Seppo Koskinen, Marek L. Kowalski, Helga Kraxner, Dmitry Kudlay, Piotr Kuna, Maciej Kupczyk, Violeta Kvedariene, Amir H. Abdul Latiff, Lan T. Le, Michael Levin, Desiree Larenas-Linnemann, Renaud Louis, Mohammad R. Masjedi, Erik Melén, Florin Mihaltan, Branislava Milenkovic, Yousser Mohammad, Mario Morais-Almeida, Joaquim Mullol, Leyla Namazova, Hugo Neffen, Elisabete Nunes, Paul O’Byrne, Robyn O’Hehir, Liam O’Mahony, Ken Ohta, Yoshitaka Okamoto, Gabrielle L. Onorato, Petr Panzner, Nikos G. Papadopoulos, Gianni Passalacqua, Vincenzo Patella, Ruby Pawankar, Nhân Pham-Thi, Bernard Pigearias, Todor A. Popov, Francesca Puggioni, Frederico S. Regateiro, Giovanni Rolla, Menachem Rottem, Boleslaw Samolinski, Joaquin Sastre, Jurgen Schwarze, Aziz Sheikh, Nicola Scichilone, Manuel Soto-Martinez, Manuel Soto-Martinez, Milan Sova, Stefania Nicola, Rafael Stelmach, Charlotte Suppli-Ulrik, Luis Taborda-Barata, Teresa To, Peter Valentin Tomazic, Sanna Toppila-Salmi, Ioanna Tsiligianni, Omar Usmani, Arunas Valiulis, Maria Teresa Ventura, Giovanni Viegi, Theodor Vontetsianos, De Yun Wang, Sian Williams, Gary W.K. Wong, Arzu Yorgancioglu, Mario Zernotti, Mihaela Zidarn, Torsten Zuberbier, Ioana Agache

^*Korrespondierende:r Autor:in für diese Arbeit

Publikation: Beitrag in Fachzeitschrift (peer-reviewed) › Artikel in Fachzeitschrift

58 Zitate (Scopus)

Originalsprache	Englisch
Seiten (von - bis)	689-697
Seitenumfang	9
Fachzeitschrift	Allergy: European Journal of Allergy and Clinical Immunology
Jahrgang	76
Ausgabenummer	3
DOIs	https://doi.org/10.1111/all.14471
Publikationsstatus	Veröffentlicht - März 2021
Extern publiziert	Ja

ASJC Scopus Sachgebiete

Immunologie und Allergologie
Immunologie

Zugriff auf Dokument

10.1111/all.14471

Andere Dateien und Links

Verknüpfung zur Publikation in Scopus

Dieses zitieren

Bousquet, J., Jutel, M., Akdis, C. A., Klimek, L., Pfaar, O., Nadeau, K. C., Eiwegger, T., Bedbrook, A., Ansotegui, I. J., Anto, J. M., Bachert, C., Bateman, E. D., Bennoor, K. S., Berghea, E. C., Bergmann, K. C., Blain, H., Bonini, M., Bosnic-Anticevich, S., Boulet, L. P., ... Agache, I. (2021). ARIA-EAACI statement on asthma and COVID-19 (June 2, 2020). Allergy: European Journal of Allergy and Clinical Immunology, 76(3), 689-697. https://doi.org/10.1111/all.14471

@article{c275c98c3e8f4cf58b0285a3c04ad51a,

title = "ARIA-EAACI statement on asthma and COVID-19 (June 2, 2020)",

keywords = "Angiotensin-Converting Enzyme 2/physiology, Asthma/complications, COVID-19/etiology, Humans, SARS-CoV-2",

author = "Jean Bousquet and Marek Jutel and Akdis, {Cezmi A.} and Ludger Klimek and Oliver Pfaar and Nadeau, {Kari C.} and Thomas Eiwegger and Anna Bedbrook and Ansotegui, {Ignacio J.} and Anto, {Josep M.} and Claus Bachert and Bateman, {Eric D.} and Bennoor, {Kazi S.} and Berghea, {Elena Camelia} and Bergmann, {Karl Christian} and Hubert Blain and Mateo Bonini and Sinthia Bosnic-Anticevich and Boulet, {Louis Philippe} and Luisa Brussino and Roland Buhl and Paulo Camargos and Canonica, {Giorgio Walter} and Victoria Cardona and Thomas Casale and Sharon Chinthrajah and M{\"u}beccel Akdis and Tomas Chivato and George Christoff and Cruz, {Alvaro A.} and Wienczyslawa Czarlewski and {Del Giacco}, Stefano and Hui Du and Yehia El-Gamal and Fokkens, {Wytske J.} and Fonseca, {Joao A.} and Yadong Gao and Mina Gaga and Bilun Gemicioglu and Maia Gotua and Tari Haahtela and David Halpin and Eckard Hamelmann and Karin Hoffmann-Sommergruber and Marc Humbert and Nataliya Ilina and Ivancevich, {Juan Carlos} and Guy Joos and Musa Khaitov and Bruce Kirenga and Knol, {Edward F.} and Ko, {Fanny W.} and Seppo Koskinen and Kowalski, {Marek L.} and Helga Kraxner and Dmitry Kudlay and Piotr Kuna and Maciej Kupczyk and Violeta Kvedariene and {Abdul Latiff}, {Amir H.} and Le, {Lan T.} and Michael Levin and Desiree Larenas-Linnemann and Renaud Louis and Masjedi, {Mohammad R.} and Erik Mel{\'e}n and Florin Mihaltan and Branislava Milenkovic and Yousser Mohammad and Mario Morais-Almeida and Joaquim Mullol and Leyla Namazova and Hugo Neffen and Elisabete Nunes and Paul O{\textquoteright}Byrne and Robyn O{\textquoteright}Hehir and Liam O{\textquoteright}Mahony and Ken Ohta and Yoshitaka Okamoto and Onorato, {Gabrielle L.} and Petr Panzner and Papadopoulos, {Nikos G.} and Gianni Passalacqua and Vincenzo Patella and Ruby Pawankar and Nh{\^a}n Pham-Thi and Bernard Pigearias and Popov, {Todor A.} and Francesca Puggioni and Regateiro, {Frederico S.} and Giovanni Rolla and Menachem Rottem and Boleslaw Samolinski and Joaquin Sastre and Jurgen Schwarze and Aziz Sheikh and Nicola Scichilone and Manuel Soto-Martinez and Manuel Soto-Martinez and Milan Sova and Stefania Nicola and Rafael Stelmach and Charlotte Suppli-Ulrik and Luis Taborda-Barata and Teresa To and Tomazic, {Peter Valentin} and Sanna Toppila-Salmi and Ioanna Tsiligianni and Omar Usmani and Arunas Valiulis and Ventura, {Maria Teresa} and Giovanni Viegi and Theodor Vontetsianos and Wang, {De Yun} and Sian Williams and Wong, {Gary W.K.} and Arzu Yorgancioglu and Mario Zernotti and Mihaela Zidarn and Torsten Zuberbier and Ioana Agache",

note = "Funding Information: IA reports and Associate Editor of Allergy. CA reports grants from Allergopharma, Idorsia, Swiss National Science Foundation, Christine K{\"u}hne‐Center for Allergy Research and Education, European Commission's Horison's 2020 Framework Programme, Cure, Novartis Research Institutes, Astra Zeneca, Scibase, advisory role in Sanofi/Regeneron. IA reports personal fees from Mundipharma, Roxall, Sanofi, MSD, Faes Farma, Hikma, UCB, Astra Zeneca, Stallergenes, Abbott, Bial. EB is a member of the Science Committee and Board of the Global Initiative for Asthma (GINA). SBA reports grants from TEVA, personal fees from TEVA, AstraZeneca, Boehringer Ingelheim, GSK, Sanofi, Mylan. JPB reports grants from AstraZeneca, Boston Scientific, GSK, Hoffman La Roche, Ono Pharma, Novartis, Sanofi, Takeda, Boehringer‐Ingelheim, Merck, personal fees from AstraZeneca, GSK, Merck, Metapharm, Novartis, Takeda, other from AstraZeneca, Boehringer‐Ingelheim, GSK, Merck, Novartis. JB reports personal fees from Chiesi, Cipla, Hikma, Menarini, Mundipharma, Mylan, Novartis, Purina, Sanofi‐Aventis, Takeda, Teva, Uriach, other from KYomed‐Innov. RB reports grants to Mainz University and personal fees from Boehringer Ingelheim, GlaxoSmithKline, Novartis, and Roche, as well as personal fees from AstraZeneca, Chiesi, Cipla, Sanofi, and Teva. VC reports personal fees from ALK, Allergopharma, Allergy Therapeutics, Diater, LETI, Thermo Fisher, Stallergenes. RSC reports grants from NIAID, CoFAR, Aimmune, DBV Technologies, Astellas, Regeneron, an Advisory member for Alladapt, Genentech, Novartis, and receives personal fees from Before Brands. AC reports grants and personal fees from GSK, SANOFI, Boehringer‐Ingelheim, Astrazeneca, Mantecorp, MYLAN, Novartis, personal fees and non‐financial support from CHIESI. SdG reports personal fees from AstraZeneca, Chiesi, Menarini, grants and personal fees from GSK, Novartis. DH reports personal fees from AstraZeneca, Chiesi, GSK, Pfizer, personal fees and non‐financial support from Boehringer Ingelheim, Novartis. TE reports other from DBV, Regeneron, grants from Innovation fund Denmark and Co‐I or scientific lead in three investigator initiated oral immunotherapy trials supported by the Allergy and Anaphylaxis Program Sickkids and serve as associate editor for Allergy. Advisory board ALK. JF reports personal fees from AstraZeneca, GSK, undipharma, grants and personal fees from Novartis. MG reports grants and personal fees from Elpen, Novartis, Menarini, grants from Galapagos, personal fees from BMS, MSD. TH reports personal fees from GSK, Mundipharma, OrionPharma. MH reports personal fees and non‐financial support from GlaxoSmithKline, personal fees from Astrazeneca, Novartis, Roche, Sanofi, Teva. JCI reports personal fees from Faes Farma, Eurofarma Argentina, other from Laboratorios Casasco, Sanofi. GJ reports grants from AstraZeneca, Chiesi, personal fees from Bayer, Eureca vzw, Teva, grants and personal fees from GlaxoSmithKline. MJ reports personal fees from ALK‐Abello, Allergopharma, Stallergenes, Anergis, Allergy Therapeutics, Circassia, Leti, Biomay, from HAL, Astra‐Zeneka, GSK, Novartis, Teva, Vectura, UCB, Takeda, Roche, Janssen, Medimmune, Chiesi, LK reports grants and personal fees from Allergopharma, LETI Pharma, MEDA/Mylan, Sanofi, personal fees from HAL Allergie, Allergy Therapeut., grants from ALK Abell{\'o}, Stallergenes, Quintiles, ASIT biotech, grants from Lofarma, AstraZeneca, GSK, Inmunotk and Membership: AeDA, DGHNO,Deutsche Akademie f{\"u}r Allergologie und klinische Immunologie, HNO‐BV GPA,EAACI. PK reports personal fees from Astra, Boehringer Ingelheim, Berlin Chemie Menarini, GSK, Lekam, Novartis, Polpharma, Mylan, Orion, Teva, Adamed. VK reports personal fees from GSK, non‐financial support from StallergenGreer, AstraZeneca, Norameda, DIMUNA. DLL reports personal fees from Allakos, Amstrong, Astrazeneca, Boehringer Ingelheim, Chiesi, DBV Technologies, Grunenthal, GSK, MEDA, Menarini, MSD, Novartis, Pfizer, Novartis, Sanofi, Siegfried, UCB, Alakos, Gossamer, grants from Sanofi, Astrazeneca, Novartis, UCB, GSK, TEVA, Boehringer Ingelheim, Chiesi, Purina institute. RL reports grants and personal fees from AZ, GSK, Novartis, grants from Chiesi, JM reports personal fees and other from SANOFI‐GENZYME & REGENERON, NOVARTIS, ALLAKOS, grants and personal fees from MYLAN Pharma, URIACH Group, personal fees from Mitsubishi‐Tanabe, Menarini, UCB, AstraZeneca, GSK, from MSD, outside the submitted work. KN reports grants and other from NIAID, FARE, personal fees and other from Regeneron, grants from EAT, other from Sanofi, Astellas, Nestle, BeforeBrands, Alladapt, ForTra, Genentech, AImmune Therapeutics, DBV Technologies, personal fees from Astrazeneca, ImmuneWorks, Cour Pharmaceuticals, grants from Allergenis, Ukko Pharma, Novartis,AnaptysBio, Adare Pharmaceuticals, Stallergenes‐Greer, NHLBI, NIEHS, EPA, WAO Center of Excellence, Iggenix, Probio, Vedanta, Centecor, Seed, Immune Tolerance Network, NIH,; In addition, Dr Nadeau has a patent Inhibition of Allergic Reaction to Peanut Allergen using an IL‐33 Inhibitor pending, a patent Special Oral Formula for Decreasing Food Allergy Risk and Treatment for Food Allergy pending, a patent Basophil Activation Based Diagnostic Allergy Test pending, a patent Granulocyte‐based methods for detecting and monitoring immune system disorders pending, a patent Methods and Assays for Detecting and Quantifying Pure Subpopulations of White Blood Cells in Immune System Disorders pending, a patent Mixed Allergen Compositions and Methods for Using the Same pending, and a patent Microfluidic Device and Diagnostic Methods for Allergy Testing Based on Detection of Basophil Activation pending. YO reports personal fees from Shionogi Co., Ltd., Torii Co., Ltd., GSK, MSD, Eizai Co.,Ltd., grants and personal fees from Kyorin Co., Ltd., Tiho Co., Ltd., grants from Yakuruto Co., Ltd., Yamada Bee Farm. ROB reports grants and personal fees from AstraZeneca, GSK, grants from Novartis, Medimmune, Bayer. YO reports personal fees from Shionogi Co., Ltd., Torii Co., Ltd., GSK, MSD, Eizai Co.,Ltd., grants and personal fees from Kyorin Co., Ltd., Tiho Co., Ltd., grants from Yakuruto Co., Ltd., Yamada Bee Farm, outside the submitted work. NP reports personal fees from Novartis, Nutricia, HAL, MENARINI/FAES FARMA, SANOFI, MYLAN/MEDA, BIOMAY, AstraZeneca, GSK, MSD, ASIT BIOTECH, Boehringer Ingelheim, grants from Gerolymatos International SA, Capricare. OP reports grants and personal fees from Anergis SA, ALK‐Abell{\'o}, Allergopharma, Stallergenes Greer, HAL Allergy Holding BV/HAL Allergie GmbH, Bencard Allergie GmbH/Allergy Therapeutics, Lofarma, ASIT Biotech Tools SA, Laboratorios LETI/LETI Pharma, grants from Biomay, Glaxo Smith Kline Circassia, personal fees from MEDA Pharma/MYLAN, Mobile Chamber Experts (a GALEN Partner), Indoor Biotechnologies, Astellas Pharma Global, EUFOREA, ROXALL, NOVARTIS, SANOFI AVENTIS, Med Update Europe GmbH, streamedup! GmbH. FP reports sanofi, novartis, teva, astrazeneca, glaxosmithkline, menarini, mundipharma, guidotti, malesci, chiesi, valeas, allergy therapeutics, almirall, personal fees from boehringer Ingelheim. FR reports personal fees from AstraZeneca, Novartis, Lusomedicamenta, Sanofi, GSK. JS reports other from MEDA, grants and personal fees from SANOFI, personal fees from GSK, NOVARTIS, ASTRA ZENECA, MUNDIPHARMA, FAES FARMA. JSchwarze reports personal fees from MYLAN, outside the submitted work. ASheikh reports support of the Asthma UK Centre for Applied Research. RS reports grants from S{\~a}o Paulo Research Foundation, MSD,grants and personal fees from Novartis, grants, personal fees and non‐financial support from AstraZeneca, Chiesi, Boehringer Ingelheim. IT reports grants from GSK Hellas, ELPEN, personal fees from Boehringer Ingelheim, Novartis, Astra Zeneca, GSK. TZ reports Organizational affiliations: Committee member: WHO‐Initiative {"}Allergic Rhinitis and Its Impact on Asthma{"} (ARIA); Member of the Board: German Society for Allergy and Clinical Immunology (DGAKI); Head: European Centre for Allergy Research Foundation (ECARF); President: Global Allergy and Asthma European Network (GALEN); Member: Committee on Allergy Diagnosis and Molecular Allergology, World Allergy Organization (WAO). The other authors have no COI to declare. 2 2",

year = "2021",

month = mar,

doi = "10.1111/all.14471",

language = "English",

volume = "76",

pages = "689--697",

journal = "Allergy: European Journal of Allergy and Clinical Immunology",

issn = "0105-4538",

publisher = "Wiley-Blackwell Publishing Ltd",

number = "3",

}

Bousquet, J, Jutel, M, Akdis, CA, Klimek, L, Pfaar, O, Nadeau, KC, Eiwegger, T, Bedbrook, A, Ansotegui, IJ, Anto, JM, Bachert, C, Bateman, ED, Bennoor, KS, Berghea, EC, Bergmann, KC, Blain, H, Bonini, M, Bosnic-Anticevich, S, Boulet, LP, Brussino, L, Buhl, R, Camargos, P, Canonica, GW, Cardona, V, Casale, T, Chinthrajah, S, Akdis, M, Chivato, T, Christoff, G, Cruz, AA, Czarlewski, W, Del Giacco, S, Du, H, El-Gamal, Y, Fokkens, WJ, Fonseca, JA, Gao, Y, Gaga, M, Gemicioglu, B, Gotua, M, Haahtela, T, Halpin, D, Hamelmann, E, Hoffmann-Sommergruber, K, Humbert, M, Ilina, N, Ivancevich, JC, Joos, G, Khaitov, M, Kirenga, B, Knol, EF, Ko, FW, Koskinen, S, Kowalski, ML, Kraxner, H, Kudlay, D, Kuna, P, Kupczyk, M, Kvedariene, V, Abdul Latiff, AH, Le, LT, Levin, M, Larenas-Linnemann, D, Louis, R, Masjedi, MR, Melén, E, Mihaltan, F, Milenkovic, B, Mohammad, Y, Morais-Almeida, M, Mullol, J, Namazova, L, Neffen, H, Nunes, E, O’Byrne, P, O’Hehir, R, O’Mahony, L, Ohta, K, Okamoto, Y, Onorato, GL, Panzner, P, Papadopoulos, NG, Passalacqua, G, Patella, V, Pawankar, R, Pham-Thi, N, Pigearias, B, Popov, TA, Puggioni, F, Regateiro, FS, Rolla, G, Rottem, M, Samolinski, B, Sastre, J, Schwarze, J, Sheikh, A, Scichilone, N, Soto-Martinez, M, Soto-Martinez, M, Sova, M, Nicola, S, Stelmach, R, Suppli-Ulrik, C, Taborda-Barata, L, To, T, Tomazic, PV, Toppila-Salmi, S, Tsiligianni, I, Usmani, O, Valiulis, A, Ventura, MT, Viegi, G, Vontetsianos, T, Wang, DY, Williams, S, Wong, GWK, Yorgancioglu, A, Zernotti, M, Zidarn, M, Zuberbier, T & Agache, I 2021, 'ARIA-EAACI statement on asthma and COVID-19 (June 2, 2020)', Allergy: European Journal of Allergy and Clinical Immunology, Jg. 76, Nr. 3, S. 689-697. https://doi.org/10.1111/all.14471

TY - JOUR

T1 - ARIA-EAACI statement on asthma and COVID-19 (June 2, 2020)

AU - Bousquet, Jean

AU - Jutel, Marek

AU - Akdis, Cezmi A.

AU - Klimek, Ludger

AU - Pfaar, Oliver

AU - Nadeau, Kari C.

AU - Eiwegger, Thomas

AU - Bedbrook, Anna

AU - Ansotegui, Ignacio J.

AU - Anto, Josep M.

AU - Bachert, Claus

AU - Bateman, Eric D.

AU - Bennoor, Kazi S.

AU - Berghea, Elena Camelia

AU - Bergmann, Karl Christian

AU - Blain, Hubert

AU - Bonini, Mateo

AU - Bosnic-Anticevich, Sinthia

AU - Boulet, Louis Philippe

AU - Brussino, Luisa

AU - Buhl, Roland

AU - Camargos, Paulo

AU - Canonica, Giorgio Walter

AU - Cardona, Victoria

AU - Casale, Thomas

AU - Chinthrajah, Sharon

AU - Akdis, Mübeccel

AU - Chivato, Tomas

AU - Christoff, George

AU - Cruz, Alvaro A.

AU - Czarlewski, Wienczyslawa

AU - Del Giacco, Stefano

AU - Du, Hui

AU - El-Gamal, Yehia

AU - Fokkens, Wytske J.

AU - Fonseca, Joao A.

AU - Gao, Yadong

AU - Gaga, Mina

AU - Gemicioglu, Bilun

AU - Gotua, Maia

AU - Haahtela, Tari

AU - Halpin, David

AU - Hamelmann, Eckard

AU - Hoffmann-Sommergruber, Karin

AU - Humbert, Marc

AU - Ilina, Nataliya

AU - Ivancevich, Juan Carlos

AU - Joos, Guy

AU - Khaitov, Musa

AU - Kirenga, Bruce

AU - Knol, Edward F.

AU - Ko, Fanny W.

AU - Koskinen, Seppo

AU - Kowalski, Marek L.

AU - Kraxner, Helga

AU - Kudlay, Dmitry

AU - Kuna, Piotr

AU - Kupczyk, Maciej

AU - Kvedariene, Violeta

AU - Abdul Latiff, Amir H.

AU - Le, Lan T.

AU - Levin, Michael

AU - Larenas-Linnemann, Desiree

AU - Louis, Renaud

AU - Masjedi, Mohammad R.

AU - Melén, Erik

AU - Mihaltan, Florin

AU - Milenkovic, Branislava

AU - Mohammad, Yousser

AU - Morais-Almeida, Mario

AU - Mullol, Joaquim

AU - Namazova, Leyla

AU - Neffen, Hugo

AU - Nunes, Elisabete

AU - O’Byrne, Paul

AU - O’Hehir, Robyn

AU - O’Mahony, Liam

AU - Ohta, Ken

AU - Okamoto, Yoshitaka

AU - Onorato, Gabrielle L.

AU - Panzner, Petr

AU - Papadopoulos, Nikos G.

AU - Passalacqua, Gianni

AU - Patella, Vincenzo

AU - Pawankar, Ruby

AU - Pham-Thi, Nhân

AU - Pigearias, Bernard

AU - Popov, Todor A.

AU - Puggioni, Francesca

AU - Regateiro, Frederico S.

AU - Rolla, Giovanni

AU - Rottem, Menachem

AU - Samolinski, Boleslaw

AU - Sastre, Joaquin

AU - Schwarze, Jurgen

AU - Sheikh, Aziz

AU - Scichilone, Nicola

AU - Soto-Martinez, Manuel

AU - Sova, Milan

AU - Nicola, Stefania

AU - Stelmach, Rafael

AU - Suppli-Ulrik, Charlotte

AU - Taborda-Barata, Luis

AU - To, Teresa

AU - Tomazic, Peter Valentin

AU - Toppila-Salmi, Sanna

AU - Tsiligianni, Ioanna

AU - Usmani, Omar

AU - Valiulis, Arunas

AU - Ventura, Maria Teresa

AU - Viegi, Giovanni

AU - Vontetsianos, Theodor

AU - Wang, De Yun

AU - Williams, Sian

AU - Wong, Gary W.K.

AU - Yorgancioglu, Arzu

AU - Zernotti, Mario

AU - Zidarn, Mihaela

AU - Zuberbier, Torsten

AU - Agache, Ioana

N1 - Funding Information: IA reports and Associate Editor of Allergy. CA reports grants from Allergopharma, Idorsia, Swiss National Science Foundation, Christine Kühne‐Center for Allergy Research and Education, European Commission's Horison's 2020 Framework Programme, Cure, Novartis Research Institutes, Astra Zeneca, Scibase, advisory role in Sanofi/Regeneron. IA reports personal fees from Mundipharma, Roxall, Sanofi, MSD, Faes Farma, Hikma, UCB, Astra Zeneca, Stallergenes, Abbott, Bial. EB is a member of the Science Committee and Board of the Global Initiative for Asthma (GINA). SBA reports grants from TEVA, personal fees from TEVA, AstraZeneca, Boehringer Ingelheim, GSK, Sanofi, Mylan. JPB reports grants from AstraZeneca, Boston Scientific, GSK, Hoffman La Roche, Ono Pharma, Novartis, Sanofi, Takeda, Boehringer‐Ingelheim, Merck, personal fees from AstraZeneca, GSK, Merck, Metapharm, Novartis, Takeda, other from AstraZeneca, Boehringer‐Ingelheim, GSK, Merck, Novartis. JB reports personal fees from Chiesi, Cipla, Hikma, Menarini, Mundipharma, Mylan, Novartis, Purina, Sanofi‐Aventis, Takeda, Teva, Uriach, other from KYomed‐Innov. RB reports grants to Mainz University and personal fees from Boehringer Ingelheim, GlaxoSmithKline, Novartis, and Roche, as well as personal fees from AstraZeneca, Chiesi, Cipla, Sanofi, and Teva. VC reports personal fees from ALK, Allergopharma, Allergy Therapeutics, Diater, LETI, Thermo Fisher, Stallergenes. RSC reports grants from NIAID, CoFAR, Aimmune, DBV Technologies, Astellas, Regeneron, an Advisory member for Alladapt, Genentech, Novartis, and receives personal fees from Before Brands. AC reports grants and personal fees from GSK, SANOFI, Boehringer‐Ingelheim, Astrazeneca, Mantecorp, MYLAN, Novartis, personal fees and non‐financial support from CHIESI. SdG reports personal fees from AstraZeneca, Chiesi, Menarini, grants and personal fees from GSK, Novartis. DH reports personal fees from AstraZeneca, Chiesi, GSK, Pfizer, personal fees and non‐financial support from Boehringer Ingelheim, Novartis. TE reports other from DBV, Regeneron, grants from Innovation fund Denmark and Co‐I or scientific lead in three investigator initiated oral immunotherapy trials supported by the Allergy and Anaphylaxis Program Sickkids and serve as associate editor for Allergy. Advisory board ALK. JF reports personal fees from AstraZeneca, GSK, undipharma, grants and personal fees from Novartis. MG reports grants and personal fees from Elpen, Novartis, Menarini, grants from Galapagos, personal fees from BMS, MSD. TH reports personal fees from GSK, Mundipharma, OrionPharma. MH reports personal fees and non‐financial support from GlaxoSmithKline, personal fees from Astrazeneca, Novartis, Roche, Sanofi, Teva. JCI reports personal fees from Faes Farma, Eurofarma Argentina, other from Laboratorios Casasco, Sanofi. GJ reports grants from AstraZeneca, Chiesi, personal fees from Bayer, Eureca vzw, Teva, grants and personal fees from GlaxoSmithKline. MJ reports personal fees from ALK‐Abello, Allergopharma, Stallergenes, Anergis, Allergy Therapeutics, Circassia, Leti, Biomay, from HAL, Astra‐Zeneka, GSK, Novartis, Teva, Vectura, UCB, Takeda, Roche, Janssen, Medimmune, Chiesi, LK reports grants and personal fees from Allergopharma, LETI Pharma, MEDA/Mylan, Sanofi, personal fees from HAL Allergie, Allergy Therapeut., grants from ALK Abelló, Stallergenes, Quintiles, ASIT biotech, grants from Lofarma, AstraZeneca, GSK, Inmunotk and Membership: AeDA, DGHNO,Deutsche Akademie für Allergologie und klinische Immunologie, HNO‐BV GPA,EAACI. PK reports personal fees from Astra, Boehringer Ingelheim, Berlin Chemie Menarini, GSK, Lekam, Novartis, Polpharma, Mylan, Orion, Teva, Adamed. VK reports personal fees from GSK, non‐financial support from StallergenGreer, AstraZeneca, Norameda, DIMUNA. DLL reports personal fees from Allakos, Amstrong, Astrazeneca, Boehringer Ingelheim, Chiesi, DBV Technologies, Grunenthal, GSK, MEDA, Menarini, MSD, Novartis, Pfizer, Novartis, Sanofi, Siegfried, UCB, Alakos, Gossamer, grants from Sanofi, Astrazeneca, Novartis, UCB, GSK, TEVA, Boehringer Ingelheim, Chiesi, Purina institute. RL reports grants and personal fees from AZ, GSK, Novartis, grants from Chiesi, JM reports personal fees and other from SANOFI‐GENZYME & REGENERON, NOVARTIS, ALLAKOS, grants and personal fees from MYLAN Pharma, URIACH Group, personal fees from Mitsubishi‐Tanabe, Menarini, UCB, AstraZeneca, GSK, from MSD, outside the submitted work. KN reports grants and other from NIAID, FARE, personal fees and other from Regeneron, grants from EAT, other from Sanofi, Astellas, Nestle, BeforeBrands, Alladapt, ForTra, Genentech, AImmune Therapeutics, DBV Technologies, personal fees from Astrazeneca, ImmuneWorks, Cour Pharmaceuticals, grants from Allergenis, Ukko Pharma, Novartis,AnaptysBio, Adare Pharmaceuticals, Stallergenes‐Greer, NHLBI, NIEHS, EPA, WAO Center of Excellence, Iggenix, Probio, Vedanta, Centecor, Seed, Immune Tolerance Network, NIH,; In addition, Dr Nadeau has a patent Inhibition of Allergic Reaction to Peanut Allergen using an IL‐33 Inhibitor pending, a patent Special Oral Formula for Decreasing Food Allergy Risk and Treatment for Food Allergy pending, a patent Basophil Activation Based Diagnostic Allergy Test pending, a patent Granulocyte‐based methods for detecting and monitoring immune system disorders pending, a patent Methods and Assays for Detecting and Quantifying Pure Subpopulations of White Blood Cells in Immune System Disorders pending, a patent Mixed Allergen Compositions and Methods for Using the Same pending, and a patent Microfluidic Device and Diagnostic Methods for Allergy Testing Based on Detection of Basophil Activation pending. YO reports personal fees from Shionogi Co., Ltd., Torii Co., Ltd., GSK, MSD, Eizai Co.,Ltd., grants and personal fees from Kyorin Co., Ltd., Tiho Co., Ltd., grants from Yakuruto Co., Ltd., Yamada Bee Farm. ROB reports grants and personal fees from AstraZeneca, GSK, grants from Novartis, Medimmune, Bayer. YO reports personal fees from Shionogi Co., Ltd., Torii Co., Ltd., GSK, MSD, Eizai Co.,Ltd., grants and personal fees from Kyorin Co., Ltd., Tiho Co., Ltd., grants from Yakuruto Co., Ltd., Yamada Bee Farm, outside the submitted work. NP reports personal fees from Novartis, Nutricia, HAL, MENARINI/FAES FARMA, SANOFI, MYLAN/MEDA, BIOMAY, AstraZeneca, GSK, MSD, ASIT BIOTECH, Boehringer Ingelheim, grants from Gerolymatos International SA, Capricare. OP reports grants and personal fees from Anergis SA, ALK‐Abelló, Allergopharma, Stallergenes Greer, HAL Allergy Holding BV/HAL Allergie GmbH, Bencard Allergie GmbH/Allergy Therapeutics, Lofarma, ASIT Biotech Tools SA, Laboratorios LETI/LETI Pharma, grants from Biomay, Glaxo Smith Kline Circassia, personal fees from MEDA Pharma/MYLAN, Mobile Chamber Experts (a GALEN Partner), Indoor Biotechnologies, Astellas Pharma Global, EUFOREA, ROXALL, NOVARTIS, SANOFI AVENTIS, Med Update Europe GmbH, streamedup! GmbH. FP reports sanofi, novartis, teva, astrazeneca, glaxosmithkline, menarini, mundipharma, guidotti, malesci, chiesi, valeas, allergy therapeutics, almirall, personal fees from boehringer Ingelheim. FR reports personal fees from AstraZeneca, Novartis, Lusomedicamenta, Sanofi, GSK. JS reports other from MEDA, grants and personal fees from SANOFI, personal fees from GSK, NOVARTIS, ASTRA ZENECA, MUNDIPHARMA, FAES FARMA. JSchwarze reports personal fees from MYLAN, outside the submitted work. ASheikh reports support of the Asthma UK Centre for Applied Research. RS reports grants from São Paulo Research Foundation, MSD,grants and personal fees from Novartis, grants, personal fees and non‐financial support from AstraZeneca, Chiesi, Boehringer Ingelheim. IT reports grants from GSK Hellas, ELPEN, personal fees from Boehringer Ingelheim, Novartis, Astra Zeneca, GSK. TZ reports Organizational affiliations: Committee member: WHO‐Initiative "Allergic Rhinitis and Its Impact on Asthma" (ARIA); Member of the Board: German Society for Allergy and Clinical Immunology (DGAKI); Head: European Centre for Allergy Research Foundation (ECARF); President: Global Allergy and Asthma European Network (GALEN); Member: Committee on Allergy Diagnosis and Molecular Allergology, World Allergy Organization (WAO). The other authors have no COI to declare. 2 2

PY - 2021/3

Y1 - 2021/3

KW - Angiotensin-Converting Enzyme 2/physiology

KW - Asthma/complications

KW - COVID-19/etiology

KW - Humans

KW - SARS-CoV-2

UR - http://www.scopus.com/inward/record.url?scp=85091138547&partnerID=8YFLogxK

U2 - 10.1111/all.14471

DO - 10.1111/all.14471

M3 - Journal article

C2 - 32588922

AN - SCOPUS:85091138547

SN - 0105-4538

VL - 76

SP - 689

EP - 697

JO - Allergy: European Journal of Allergy and Clinical Immunology

JF - Allergy: European Journal of Allergy and Clinical Immunology

IS - 3

ER -